---
schema_version: "secwatch.filing_event.v1"
accession: "0001104659-23-064177"
form_type: "8-K"
ticker: "BCLI"
cik: "0001137883"
company_name: "BRAINSTORM CELL THERAPEUTICS INC."
filed_at: "2023-05-24T23:59:59+00:00"
generated_at: "2026-06-14T15:39:45.935144+00:00"
event_type: "leadership"
sentiment: "neutral"
materiality_score: 0.5
calibrated_materiality_score: 0.5
confidence: "high"
source: SEC EDGAR
---

# Brainstorm Cell Therapeutics COO David Setboun resigns effective May 31, 2023

## Summary
- David Setboun, PhD, MBA, EVP and COO, notified resignation on May 18, 2023.
- Resignation effective May 31, 2023; he is leaving to pursue another opportunity.
- Dr. Setboun's decision was not due to any disagreement with the company's operations, policies, or practices.
- BCLI has not announced a replacement for the COO role.

## SEC filing metadata
- accession: 0001104659-23-064177
- form_type: 8-K
- ticker: BCLI
- cik: 0001137883
- company_name: BRAINSTORM CELL THERAPEUTICS INC.
- filed_at: 2023-05-24T23:59:59+00:00
- event_type: leadership
- sentiment: neutral
- materiality_score: 0.5
- calibrated_materiality_score: 0.5
- confidence: high
- sec_items: 5.02
- EDGAR index: https://www.sec.gov/Archives/edgar/data/1137883/000110465923064177/0001104659-23-064177-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/1137883/000110465923064177/tm2316879d1_8k.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001104659-23-064177
- JSON: https://secwatch.observer/filing/0001104659-23-064177.json
- Plain text: https://secwatch.observer/filing/0001104659-23-064177.txt

## Key facts
- Executive change
  David Setboun resigned as Chief Operating Officer at BRAINSTORM CELL THERAPEUTICS INC..
  - Action: resigned
  - Role: Chief Operating Officer
  source text: On May 18, 2023, David Setboun, PhD, MBA, Executive Vice President and Chief Operating Officer of Brainstorm Cell Therapeutics Inc. (the “Company”), notified the Company of his decision to resign from his role effective as of May 31, 2023 to pursue another opportunity.
  evidence_url: https://www.sec.gov/Archives/edgar/data/1137883/000110465923064177/0001104659-23-064177-index.htm

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.